• LEVITY
  • Posts
  • ”We could already be on the way to 120-year lifespans”

”We could already be on the way to 120-year lifespans”

Plus: Woolly mice! Spelling the end for heart disease! Astonishing new sequencing tech!

In this week’s newsletter

✅ Why are we not talking about the ”other” amyloid? ✅ What a woolly mouse could mean for longevity. ✅ One of the most important companies in the world. ✅ Insilicos AI drug has anti-aging properties. ✅ Say hello to our next guest on the LEVITY podast.

🤙🏼 Want to connect? Add me on LinkedIn. 🙏🏼 Not subscribed to the LEVITY podcast on Youtube yet? Do it here. 🎧 More of a listener? The LEVITY podcast is also available on Spotify, Apple Podcasts and other places.

Gene editing could spell the end for heart disease

Ever since I first learned about Verve Therapeutics - and researched and wrote about it in my book, Evigt Ung - I’ve believed it's one of the most important companies in the world today. Yet chances are, you've never heard of them.

Let me back up a bit.

Subscribe to LEVITY Premium to read the rest.

Become a paying subscriber of LEVITY Premium to get access to this post and other subscriber-only content.

Already a paying subscriber? Sign In.

A subscription gets you:

  • • Exclusive content
  • • Full access to the archive
  • • Ad-free experience
  • • My gratitude